3isq
From Proteopedia
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
| - | [[Image:3isq.jpg|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3isq", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3isq| PDB=3isq | SCENE= }} | {{STRUCTURE_3isq| PDB=3isq | SCENE= }} | ||
| - | |||
===Crystal structure of human 4-Hydroxyphenylpyruvate dioxygenase=== | ===Crystal structure of human 4-Hydroxyphenylpyruvate dioxygenase=== | ||
| - | |||
==Disease== | ==Disease== | ||
| - | + | [[http://www.uniprot.org/uniprot/HPPD_HUMAN HPPD_HUMAN]] Defects in HPD are the cause of tyrosinemia type 3 (TYRO3) [MIM:[http://omim.org/entry/276710 276710]]. TYRO3 is an inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, seizures and mild mental retardation.<ref>PMID:10942115</ref><ref>PMID:11073718</ref> Defects in HPD are a cause of hawkinsinuria (HAWK) [MIM:[http://omim.org/entry/140350 140350]]. HAWK is an inborn error of tyrosine metabolism characterized by failure to thrive, persistent metabolic acidosis, fine and sparse hair, and excretion of the unusual cyclic amino acid metabolite, hawkinsin, in the urine.<ref>PMID:11073718</ref> | |
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/HPPD_HUMAN HPPD_HUMAN]] Key enzyme in the degradation of tyrosine. | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[3isq]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ISQ OCA]. | |
| + | |||
| + | ==Reference== | ||
| + | <references group="xtra"/><references/> | ||
[[Category: 4-hydroxyphenylpyruvate dioxygenase]] | [[Category: 4-hydroxyphenylpyruvate dioxygenase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 35: | Line 30: | ||
[[Category: Weigelt, J.]] | [[Category: Weigelt, J.]] | ||
[[Category: Yue, W W.]] | [[Category: Yue, W W.]] | ||
| - | [[Category: Acetylation]] | ||
[[Category: Dioxygenase]] | [[Category: Dioxygenase]] | ||
[[Category: Disease mutation]] | [[Category: Disease mutation]] | ||
| Line 45: | Line 39: | ||
[[Category: Phenylalanine catabolism]] | [[Category: Phenylalanine catabolism]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
| - | [[Category: Polymorphism]] | ||
[[Category: Sgc]] | [[Category: Sgc]] | ||
[[Category: Structural genomic]] | [[Category: Structural genomic]] | ||
| Line 51: | Line 44: | ||
[[Category: Tyrosine catabolism]] | [[Category: Tyrosine catabolism]] | ||
[[Category: Tyrosine metabolism]] | [[Category: Tyrosine metabolism]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 16 09:14:05 2009'' | ||
Revision as of 18:07, 24 March 2013
Contents |
Crystal structure of human 4-Hydroxyphenylpyruvate dioxygenase
Disease
[HPPD_HUMAN] Defects in HPD are the cause of tyrosinemia type 3 (TYRO3) [MIM:276710]. TYRO3 is an inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, seizures and mild mental retardation.[1][2] Defects in HPD are a cause of hawkinsinuria (HAWK) [MIM:140350]. HAWK is an inborn error of tyrosine metabolism characterized by failure to thrive, persistent metabolic acidosis, fine and sparse hair, and excretion of the unusual cyclic amino acid metabolite, hawkinsin, in the urine.[3]
Function
[HPPD_HUMAN] Key enzyme in the degradation of tyrosine.
About this Structure
3isq is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Ruetschi U, Cerone R, Perez-Cerda C, Schiaffino MC, Standing S, Ugarte M, Holme E. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III. Hum Genet. 2000 Jun;106(6):654-62. PMID:10942115
- ↑ Tomoeda K, Awata H, Matsuura T, Matsuda I, Ploechl E, Milovac T, Boneh A, Scott CR, Danks DM, Endo F. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab. 2000 Nov;71(3):506-10. PMID:11073718 doi:10.1006/mgme.2000.3085
- ↑ Tomoeda K, Awata H, Matsuura T, Matsuda I, Ploechl E, Milovac T, Boneh A, Scott CR, Danks DM, Endo F. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Mol Genet Metab. 2000 Nov;71(3):506-10. PMID:11073718 doi:10.1006/mgme.2000.3085
Categories: 4-hydroxyphenylpyruvate dioxygenase | Homo sapiens | Arrowsmith, C H. | Bountra, C. | Bray, J E. | Cocking, R. | Delft, F von. | Edwards, A. | Kavanagh, K L. | Krojer, T. | Oppermann, U. | Pike, A C.W. | Pilka, E S. | SGC, Structural Genomics Consortium. | Shafqat, N. | Weigelt, J. | Yue, W W. | Dioxygenase | Disease mutation | Hydroxyphenylpyruvate | Iron | Mental retardation | Metal-binding | Oxidoreductase | Phenylalanine catabolism | Phosphoprotein | Sgc | Structural genomic | Structural genomics consortium | Tyrosine catabolism | Tyrosine metabolism
